<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SYSU-CHINA_Results skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SYSU-CHINA/Results</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="nav"><UL class="menu" style="left:260px;margin:16px 0 0 10px;"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA">HOME</A></LI><LI><A href="#">PROJECT</A></LI><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Description">Description</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Design">Design</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Demonstrate">Demonstrate</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Applied_Design">Applied Design</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Notebook">Notebook&amp;Experiments</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/InterLab">InterLab</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Measurement">Measurement</A></LI></UL><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Model">MODEL</A></LI><LI><A href="#">PARTS</A></LI><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Parts">Parts Overview</A></LI><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Basic_Part">Basic Parts</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Improve">Improve</A></LI></UL><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Safety">SAFETY</A></LI><LI><A href="#">HUMAN PRACTICES</A></LI><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Human_Practices">Human Practices</A></LI><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Public_Engagement">Public Engagement</A></LI></UL><LI><A href="#">TEAM</A></LI><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Team">Team Members</A></LI><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Attributions">Attributions</A></LI></UL><UL class="submenu"><LI><A href="https://2018.igem.org/Team:SYSU-CHINA/Collaborations">Collaborations</A></LI></UL></DIV><DIV class="igem_2018_team_content"><DIV class="igem_2018_team_column_wrapper"><DIV id="left" style="width:18%;height:1px;position:fixed;top:238px;"><DIV id="leftnav" style="width:75%;float:left;overflow:hidden"><UL style="margin:0;"><LI><A href="#Results" onmousemove="click()" style="text-decoration:none;word-break:break-all;cursor:pointer;">Results</A></LI><LI><A href="#Human Practices" onmousemove="click()" style="text-decoration:none;word-break:break-all;cursor:pointer;">Human Practices</A></LI></UL></DIV></DIV><DIV id="main" style="width:80%;float:left;border:10px solid #C2BBB6"><DIV style="width:100%"><DIV style="width:100%;text-align:center;"><H1>Results</H1></DIV><DIV style="width:30%;margin-left:2%;float:left;"><P style="text-align:justify;text-justify:inter-ideograph">
			 In order to test the ability of U24 and our device to downregulate CAR receptors,we first need to construct cell line that express CAR.We have constructed vector that express anti-CD19 CAR under the control of EF-1α promoter.
			 </P></DIV><DIV style="width:30%;margin-left:3%;margin-right:3%;float:left;"><P style="text-align:justify;text-justify:inter-ideograph">
			 To verify U24's ability to downregulate CARs,we have constructed vector that express anti-CD19 CAR under the control of EF-1α promoter.As a control,we constructed a defective mutant of U24.
			 </P></DIV><DIV style="width:30%;float:left;"><P style="text-align:justify;text-justify:inter-ideograph">
			 For our final device,we constructed vector that both expresses doxycycline responsive transcriptional factor rtTA consititutively under the promoter UbC,and expresses GFP-T2A-U24 in response to doxycycline under the control of tetON promoter.
			 </P></DIV></DIV><DIV style="width:100%"><DIV style="width:96%;text-align:center;"><H1>Human Practices</H1></DIV></DIV><DIV style="width:100%;"><DIV style="width:68%;float:left;"><DIV style="width:100%;padding-left:10px;"><DIV style="width:50%;"><DIV style="width:40%;float:left;"><P>
						 Joint Conference 
						 organized by 
						 NKU_CHINA
						</P></DIV></DIV><DIV style="width:50%;float:left;"><DIV style="width:40%;float:left;"><P style="padding:10px">
						 Communacation with
						 High school team
						</P></DIV></DIV><DIV style="width:50%;"><DIV style="width:40%;float:left;"><P>
						 2018 iGEM Southern
						 China Regional
						 Meeting
						</P></DIV></DIV><DIV style="width:50%;float:left;"><DIV style="width:40%;float:left;"><P style="padding:10px">
						 5th CCIC in 
						 Shanghai Tech 
						 university
						</P></DIV></DIV></DIV></DIV><DIV style="width:30%;height:280px;text-align:center;border-left:2px solid gray;float:left;"><H4>What do you think of
			         CAR-T therapy ?</H4>
				 Email your point of view to<SPAN style="font-weight:bold;">taoy8@mail2.sysu.edu.cn</SPAN>
				 
				 and your name will be on our 
				 gratitude list
			</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>